ADVERTISEMENT

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

Acta Anaesthesiologica Scandinavica

Acta Anaesthesiologica Scandinavica

Volume 51 Issue 6, Pages 736 - 741

Published Online: 10 Apr 2007

Journal compilation © 2010 The Acta Anaesthesiologica Scandinavica Foundation



< Previous Abstract  |  Next Abstract >

Save Article to My Profile      Download Citation      Request Permissions

Abstract |  References  |  Full Text: HTML, PDF (Size: 78K)  | Related Articles | Citation Tracking

Tramadol does not prolong the effect of ropivacaine 7.5 mg/ml for axillary brachial plexus block
E. Kesimci 1 , S. Izdes 1 , M. Gozdemir 1 O. Kanbak 1
  1 Ataturk Training and Research Hospital, Ankara, Turkey
Correspondence to  Dr Elvin Kesimci
Ahmet Taner Kıslalı Mah.
Oyak 4 No:1/28 Cayyolu
Ankara 06810
Turkey
e-mail: elvinku@yahoo.com
Copyright 2007 The Authors Journal compilation
KEYWORDS
analgesia • brachial plexus block • local anesthetic • regional anesthesia • ropivacaine • tramadol

ABSTRACT

Background: The aim of this prospective, randomized, double-blind study was to evaluate the effect of the addition of tramadol to ropivacaine on the onset and duration of sensory and motor block, and duration of analgesia, for axillary brachial plexus block.

Methods: After institutional approval and informed consent had been obtained, 45 patients scheduled for forearm or hand surgery under axillary brachial plexus block were randomly allocated into two groups. The ropivacaine group received 40 ml of ropivacaine 7.5 mg/ml plus 2 ml of isotonic sodium chloride solution, and the tramadol group received 40 ml of ropivacaine 7.5 mg/ml plus 2 ml (100 mg) of tramadol. The onset and duration of sensory and motor block in the distribution of the musculocutaneous, radial, median and ulnar nerves, the duration of analgesia, the time to first pain medication, hemodynamics and side-effects were recorded.

Results: The addition of tramadol did not improve the speed of onset or increase the duration of sensory and motor block. The durations of analgesia were 631 ± 33 min and 633 ± 37 min (mean ± standard deviation) in the ropivacaine and tramadol groups, respectively (P > 0.05). Hemodynamic parameters and side-effects did not differ between the groups.

Conclusion: The addition of 100 mg of tramadol to 7.5 mg/ml of ropivacaine, for axillary brachial plexus block, does not prolong the duration of motor and sensory block and analgesia.


Accepted for publication 15 February 2007

DIGITAL OBJECT IDENTIFIER (DOI)
10.1111/j.1399-6576.2007.01308.x About DOI

Related Articles

  • Find other articles like this in Wiley InterScience
  • Find articles in Wiley InterScience written by any of the authors

Wiley InterScience is a member of CrossRef.

Cross Ref Member


ESA 2010 - Register Now
Sign Up Now
Sign Up Now
Submit your article today
Sign Up Now
Wiley Medical Twitter
Sign Up Now

Sign Up Now

Be the first to know about new research in your field

Sign up for FREE e-alerts from Wiley-Blackwell journals!

Sign Up Now